News

Teva Pharmaceutical has reported that the US District Court for the District of Delaware has issued a decision in its litigation over the company’s Abbreviated New Drug Application

The University of Cambridge and Life Technologies have formed a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through

Aastrom Biosciences will initiate its second clinical trial for the treatment of dilated cardiomyopathy (DCM), after a positive 30-day review of Aastrom’s Investigational New Drug (IND) submission by

Dara BioSciences’s compound for Type 2 diabetes (T2D) has demonstrated superior performance to comparator drugs at the Cambridge Healthtech Institute’s Conference, ‘Targeting Diabetes with Novel Therapeutics.’ Mary Kay

Thermo Fisher believes that Inverness Medical’ decision to terminate the contract and sell direct to customers was made in response to the company’s recent strategic decision to expand

Mankind Pharma (Mankind) has received government of Himachal Pradesh’s approval to establish another facility in the state, stated the company. Reportedly, the company has installed its second unit

Ironwood Pharmaceuticals (Ironwood ) and Astellas Pharma have entered into an agreement providing Astellas exclusive rights to develop and commercialise the investigational compound linaclotide in Japan, Indonesia, Korea,

Novavax has begun a Phase IIa clinical study of its trivalent seasonal influenza VLP vaccine candidate in healthy adults 60 years of age or older. The company said

Trin Pharma has appointed Stefan Wohlfeil as a new CEO of the company, effective from October 6, 2009. Reportedly, Dr Stefan Wohlfeil previously held the position of chief